|
Spizobactin vet 750000 IU/125 mg
|
-
|
V/DCP/17/0037
|
Le Vet Beheer B.V., Nīderlande
|
QJ01RA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Spiramycin, Metronidazole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
27-Sep-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 11032024LI (11-Mar-2024)
|
| Labelling text: |
[DOCX] 11032024M (11-Mar-2024)
|
| Summary of product characteristics: |
[DOCX] 11032024ZA (11-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0037-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0037-02 |
|
2 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0037-03 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0037-04 |
|
10 |
Kastīte ar blisteri, 10 tablete |
-
|
| V/DCP/17/0037-05 |
|
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|
|
Spizobactin vet 1500000 IU/250 mg
|
-
|
V/DCP/17/0038
|
Le Vet Beheer B.V., Nīderlande
|
QJ01RA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Spiramycin, Metronidazole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
27-Sep-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 11032024LI (11-Mar-2024)
|
| Labelling text: |
[DOCX] 11032024M (11-Mar-2024)
|
| Summary of product characteristics: |
[DOCX] 11032024ZA (11-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0038-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0038-02 |
|
2 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0038-03 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0038-04 |
|
10 |
Kastīte ar blisteri, 10 tablete |
-
|
| V/DCP/17/0038-05 |
|
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|
|
Spizobactin vet 3000000 IU/500 mg
|
-
|
V/DCP/17/0039
|
Le Vet Beheer B.V., Nīderlande
|
QJ01RA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Spiramycin, Metronidazole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
27-Sep-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 11032024LI (11-Mar-2024)
|
| Labelling text: |
[DOCX] 11032024M (11-Mar-2024)
|
| Summary of product characteristics: |
[DOCX] 11032024ZA (11-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0039-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0039-02 |
|
2 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0039-03 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0039-04 |
|
10 |
Kastīte ar blisteri, 10 tablete |
-
|
| V/DCP/17/0039-05 |
|
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|